A Multicenter Study of Belantamab Mafodotin and Mezigdomide in Patients With Relapsed Multiple Myeloma
Clinical trial NCT07612787 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07612787
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2028-01-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.